LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

BackgroundRadioresistance-induced local failure, which can result in residual or recurrent tumors, remains one of the major causes of treatment failure in nasopharyngeal carcinoma (NPC). Lipocalin 2 (LCN2) is known to play important roles in cancer initiation, progression, and treatment responses. H...

Full description

Bibliographic Details
Main Authors: Meng-Xia Zhang, Li Wang, Lei Zeng, Zi-Wei Tu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
nasopharyngeal carcinoma
lipocalin 2
hypoxia-inducible factor 1-alpha
radioresistance
recurrence
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.605777/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.605777/full

Similar Items